CD8A and neoplasm: Vaccination of transgenic HLA-A2/HER2 mice with a single dose of EVs from adenoviral vector-transfected dendritic cells activated the cytolytic function of CD8+T cells against breast cancer cells in vitro and reduced tumor growth in vivo [12].